6 results about "Genus staphylococcus" patented technology

The invention discloses a staphylococcus saprophyticus NCSL-YWH2, and the preservation number of the staphylococcus saprophyticus NCSL-YWH2 is CGMCC (China General Microbiological Culture Collection Center) No.35847. The staphylococcus saprophyticus NCSL-YWH2 has the advantages that the staphylococcus saprophyticus The invention also discloses a culture method of the staphylococcus saprophyticus NCSL-YWH2 and an application of the staphylococcus saprophyticus NCSL-YWH2 in enriching a lithium element in a lithium-containing liquid. The staphylococcus saprophyticus NCSL-YWH2 disclosed by the invention is a staphylococcus microorganism which is reported for the first time and has the capability of enriching lithium ions from a lithium-containing liquid. The strain can be widely applied to lithium extraction of salt lake brine, unconventional lithium-containing water resources and various lithium-containing industrial wastewater, efficient enrichment and concentration of lithium ions can be realized by utilizing the strain, and a biological method has the characteristics of greenness and low carbon.

Disclosed here are phage compositions for infecting and / or killing Staphylococcus spp.

This application provides a *Staphylococcus pseudoci* AT8 strain for degrading antibiotics and its application. The *Staphylococcus pseudoci* is a species of Staphylococcus (…). Staphylococcus The *Staphylococcus pseudocarpa* species, having a 16S rDNA sequence as shown in SEQ ID NO:1, is named... Staphylococcus pseudoxylosus AT8, deposited on November 20, 2025 at the Guangdong Provincial Center for Microbial Culture Collection, accession number: GDMCC No: 67323. This application pertains to *Staphylococcus pseudocarpa*. Staphylococcus pseudoxylosus AT8 can achieve a degradation rate of over 90% for trimethoprim and tilmicosin, and over 78% for enrofloxacin. Furthermore, this application enriches the antibiotic-degrading bacterial strain library, promotes the control of new antibiotic pollutants in livestock and poultry manure and farmland soil, and facilitates the resource-based treatment and safe utilization of solid waste, demonstrating broad application prospects.

[Problem] To provide a novel composition having gut microbiota regulating effect. [Solution] A composition for regulating gut microbiota, the composition being characterized by containing a sulfated polysaccharide that induces gut bacteria interactions in a host and alters the profile of the microbiota so that bacteria contributing to improving the host's health proliferate and pathogens are suppressed. The sulfated polysaccharide is preferably rhamnan sulfate. It is also preferable that the gut microbiota regulation (1) augments at least one selected from the group consisting of Prevotellaceae UCG-001, the Clostridia vadinBB60 group, and Mucispirillum schaedleri and (2) decreases at least one selected from the group consisting of the Rikenellaceae RC9 gut group, ASF356, and Staphylococcus.

Naphthoquinone derivatives have anti-inflammatory, antifungal and antibacterial effects. The naphthoquinone derivatives are able to effectively inhibit expression of inflammatory factors and be used for treating infections caused by Candida and Staphylococcus. In addition, an anti-inflammatory method is provided which includes administering the naphthoquinone derivatives for treatment, and a method of treating microbial infection includes administering the naphthoquinone derivatives for treatment.

Methods for identifying an individual having a predisposition to developing acne, for assessing severity of acne lesions, and for personalized prevention, diagnosis, and treatment of acne are disclosed. The methods include: (a) obtaining microbiome sample from skin of an individual; (b) determining an amount of one or more bacteria in the microbiome sample, wherein the one or more bacteria are selected from Lawsonella, Cutibacterium, Staphylococcus, Corynebacterium, Streptococcus, Micrococcus, and Neisseriaceae; (c) comparing the amount of the one or more bacteria to a control; and (d) identifying a difference between the amount of the one or more bacteria in the microbiome sample and the control.